MDB Capital Holdings, LLC (NASDAQ:MDBH – Get Free Report) insider Christopher Marlett purchased 4,387 shares of the company’s stock in a transaction that occurred on Wednesday, December 31st. The shares were bought at an average cost of $3.35 per share, with a total value of $14,696.45. Following the transaction, the insider directly owned 166,720 shares of the company’s stock, valued at $558,512. The trade was a 2.70% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.
MDB Capital Trading Up 0.3%
Shares of MDBH traded up $0.01 during mid-day trading on Wednesday, reaching $3.26. The company had a trading volume of 20,749 shares, compared to its average volume of 9,823. MDB Capital Holdings, LLC has a fifty-two week low of $3.11 and a fifty-two week high of $7.98. The stock has a market cap of $33.06 million, a price-to-earnings ratio of 3.51 and a beta of 1.08. The firm has a fifty day simple moving average of $3.54 and a 200-day simple moving average of $3.79.
MDB Capital (NASDAQ:MDBH – Get Free Report) last posted its quarterly earnings results on Thursday, November 13th. The company reported ($0.46) earnings per share (EPS) for the quarter. The business had revenue of $1.42 million during the quarter.
Wall Street Analysts Forecast Growth
Check Out Our Latest Report on MDB Capital
Institutional Investors Weigh In On MDB Capital
An institutional investor recently bought a new position in MDB Capital stock. Citadel Advisors LLC purchased a new position in shares of MDB Capital Holdings, LLC (NASDAQ:MDBH – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 12,569 shares of the company’s stock, valued at approximately $43,000. Citadel Advisors LLC owned approximately 0.13% of MDB Capital at the end of the most recent quarter. 0.35% of the stock is owned by institutional investors.
MDB Capital Company Profile
MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.
See Also
- Five stocks we like better than MDB Capital
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for MDB Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDB Capital and related companies with MarketBeat.com's FREE daily email newsletter.
